HIV-1 C4-V3 Polyvalent Peptide Vaccine
DATRI 101
Phase 1 mab completed
Quick answer
HIV-1 C4-V3 Polyvalent Peptide Vaccine for HIV Infections is a Phase 1 program (mab) at Praxis Precision Medicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Praxis Precision Medicines
- Indication
- HIV Infections
- Phase
- Phase 1
- Modality
- mab
- Status
- completed